Gene Directed Enzyme Prodrug Therapy for Ovarian Cancer: Could GDEPT Become a Promising Treatment Against Ovarian Cancer?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|8|2|232-239

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.8, Iss.2, 2008-02, pp. : 232-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcriptional Targeting for Ovarian Cancer Gene Therapy

By Casado E. Nettelbeck D.M. Gomez-Navarro J. Hemminki A. Gonzalez Baron M. Siegal G.P. Barnes M.N. Alvarez R.D. Curiel D.T.

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 229-237

Elsevier

Access to resources Recommend Favorite

Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter

By Bao R. Selvakumaran M. Hamilton T.C.

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 228-234

Elsevier

Access to resources Recommend Favorite

Consolidation therapy for ovarian cancer

By Huang Gloria Goldberg Gary Fields Abbie

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 3-8

Informa Healthcare

Access to resources Recommend Favorite

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

By Luo Hong

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 937-945

Springer Publishing Company

Access to resources Recommend Favorite

Epothilones in the treatment of ovarian cancer

By Diaz-Padilla Ivan Oza Amit M

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 559-568

Future Medicine

Access to resources Recommend Favorite